Buy NovoSeven 1 mg online, Buy Recombinant factor VIIa (rFVIIa) 1 mg online.
NovoSeven (Recombinant factor VIIa) 1 mg helps to prevent or control bleeding in patients with hemophilia A or hemophilia B who have clotting factor inhibitors.
NovoSeven is manufactured & marketed by Novo Nordisk. NovoSeven / Recombinant factor VIIa may also be used to treat bleeding in patients with factor VII deficiency or in select patients who have other types of bleeding problems. Compare coagulation factors.
Indications:
Coagulation Factor VIIa is indicated in Bleeding episodes in patients with haemophilia, Bleeding episodes due to surgery or invasive procedures in patients with factor VII deficiency, Bleeding episodes due to surgery or invasive procedures in Glanzmann’s thrombasthenia
Therapeutic Class:
Anti-fibrinolytic drugs
Pharmacology:
Recombinant factor VIIa is a biosynthetic preparation of activated factor VII produced by recombinant DNA technology. It is a vitamin K-dependent glycoprotein.
It promotes haemostasis by activating the extrinsic pathway of the coagulation cascade. It replaces deficient activated coagulation factor VII, which complexes with tissue factor and may activate coagulation factor X and factor IX. Factor VIIa is given as the recombinant form, eptacog alfa (activated).
Dosage & Administration:
Bleeding episodes in patients with haemophilia:
-
Adult: As activated eptacog alfa: Initially, 90 mcg/kg given via IV bolus over 2-5 min. Additional dose may be given as needed to achieve or maintain haemostasis, initially 2-3 hrly. May adjust dose or dosing interval according to response. May continue therapy for up to 3 wk or more in cases of serious bleeding episodes.
Bleeding episodes due to surgery or invasive procedures in patients with factor VII deficiency:
-
Adult: As activated eptacog alfa: 15-30 mcg/kg 4-6 hrly via IV bolus over 2-5 min until haemostasis is achieved.
Bleeding episodes due to surgery or invasive procedures in Glanzmann’s thrombasthenia:
-
Adult: As activated eptacog alfa: 90 mcg/kg 2 hrly via IV bolus over 2-5 min, give at least 3 doses.